Cassava Sciences
Open
Market Cap
High
Low
Close
Volume
P/E Ratio
Div/Yield
About Cassava Sciences
Cassava Sciences, Inc. 是一家處於臨床階段的生物技術公司，致力於開發治療神經退行性疾病的藥物。其領先的治療候選產品是simufilam，一種小分子藥物，已完成2b期臨床試驗；和研究診斷產品候選者是 SavaDx，一種基於血液的生物標誌物/診斷劑，用於檢測阿爾茨海默氏病。該公司前身為 Pain Therapeutics, Inc.，並於 2019 年 3 月更名為 Cassava Sciences, Inc.。Cassava Sciences, Inc. 成立於 1998 年，總部位於德克薩斯州奧斯汀。
如何購買 Cassava Sciences (SAVA)
登入
1分鐘開戶
僅需1分鐘即可完成帳戶申請和驗證。整個過程完全自助，支援 RockFlow App 和網頁端操作。
充值資金
帳戶驗證完成後，您可以使用首選的支付方式向帳戶充值。
購買 SAVA
透過 RockFlow App 或網頁端搜尋 SAVA，輸入您想要投資的金額，然後點擊確認即可完成交易。
Similar Stocks
© Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.